Current Controversies and Challenges in Brugada Syndrome
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional ris...
Enregistré dans:
Auteurs principaux: | Afik D Snir, Hariharan Raju |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Insights for Stratification of Risk in Brugada Syndrome
par: Daniel García Iglesias, et autres
Publié: (2019) -
Brugada Syndrome: Progress in Diagnosis and Management
par: Carlo Pappone, et autres
Publié: (2019) -
Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
par: Jorge Romero, et autres
Publié: (2019) -
Featuring: Josep Brugada
par: Josep Brugada
Publié: (2019) -
Type‐I Paradox of Brugada Syndrome
par: Sami Viskin, et autres
Publié: (2018)